Terms: = Ovarian cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181
12 results:
1. The
Makarova M; Nemtsova M; Danishevich A; Chernevskiy D; Belenikin M; Krinitsina A; Baranova E; Sagaydak O; Vorontsova M; Khatkov I; Zhukova L; Bodunova N; Nikolaev S; Byakhova M; Semenova A; Galkin V; Gadzhieva S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175647
[TBL] [Abstract] [Full Text] [Related]
2. NUF2 promotes tumorigenesis by interacting with hnrnpa2b1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract] [Full Text] [Related]
3. Identification of miR-30c-5p as a tumor suppressor by targeting the m
Wu Q; Li G; Gong L; Cai J; Chen L; Xu X; Liu X; Zhao J; Zeng Y; Gao R; Yu L; Wang Z
Cancer Med; 2023 Feb; 12(4):5055-5070. PubMed ID: 36259156
[TBL] [Abstract] [Full Text] [Related]
4. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
[TBL] [Abstract] [Full Text] [Related]
5. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer.
Fu Y; Katsaros D; Biglia N; Wang Z; Pagano I; Tius M; Tiirikainen M; Rosser C; Yang H; Yu H
Sci Rep; 2021 Apr; 11(1):7484. PubMed ID: 33820921
[TBL] [Abstract] [Full Text] [Related]
6. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in ovarian Tumour Models.
Althurwi SI; Yu JQ; Beale P; Huq F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
[TBL] [Abstract] [Full Text] [Related]
7. Loss of hnrnpa2b1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer.
Yang Y; Wei Q; Tang Y; Yuanyuan Wang ; Luo Q; Zhao H; He M; Wang H; Zeng Q; Lu W; Xu J; Liu T; Yi P
Cancer Lett; 2020 Apr; 475():43-52. PubMed ID: 32006618
[TBL] [Abstract] [Full Text] [Related]
8. ISG15 suppresses translation of ABCC2 via ISGylation of hnrnpa2b1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells.
Wang JM; Liu BQ; Zhang Q; Hao L; Li C; Yan J; Zhao FY; Qiao HY; Jiang JY; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118647. PubMed ID: 31926942
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer.
Kashima K; Yahata T; Fujita K; Tanaka K
Int J Gynaecol Obstet; 2013 Apr; 121(1):53-5. PubMed ID: 23352733
[TBL] [Abstract] [Full Text] [Related]
10. BRCA1 modulates the expression of hnrnpa2b1 and KHSRP.
Santarosa M; Del Col L; Viel A; Bivi N; D'Ambrosio C; Scaloni A; Tell G; Maestro R
Cell Cycle; 2010 Dec; 9(23):4666-73. PubMed ID: 21099359
[TBL] [Abstract] [Full Text] [Related]
11. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract] [Full Text] [Related]
12. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract] [Full Text] [Related]
